Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
about
Sipuleucel-T for metastatic castration-resistant prostate cancerSipuleucel-T for metastatic castration-resistant prostate cancerHormone naïve prostate cancer: predicting and maximizing response intervalsThe 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD)--where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial.Adverse effects of androgen-deprivation therapy in prostate cancer and their management.International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries.
P2860
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Is intermittent androgen-depri ...... with advanced prostate cancer?
@en
type
label
Is intermittent androgen-depri ...... with advanced prostate cancer?
@en
prefLabel
Is intermittent androgen-depri ...... with advanced prostate cancer?
@en
P2093
P2860
P356
P1433
P1476
Is intermittent androgen-depri ...... with advanced prostate cancer?
@en
P2093
Fernando Calais da Silva
Jacques Irani
Johannes M Wolff
Per-Anders Abrahamsson
P2860
P304
P356
10.1111/BJU.12626
P577
2014-04-16T00:00:00Z